Drugs News and Research

RSS

Arrowhead initiates Phase 1 study of ARC-520 for treatment against chronic HBV infection

Arrowhead Research Corporation (NASDAQ: ARWR), a biopharmaceutical company developing targeted RNAi therapeutics, today announced that it completed enrollment in a Phase 1 clinical trial of ARC-520, its RNAi-based candidate against chronic hepatitis B virus infection.

9 Oct 2013

MNK-795 for acute pain management: an interview with Dr Lynn Webster

MNK-795 is a product in development that is intended to be used for acute pain. It has some unique properties. First, it is an extended release formulation, meaning that it’s going to last more than three to four hours. It was studied to be dosed once every 12 hours, and that is unique for an acute pain formulation.

8 Oct 2013

Forma Achieves First Milestone In Celgene Collaboration

...

8 Oct 2013

J&J's Janssen Buys Rights To Hepatitis C Compound From GSK

...

8 Oct 2013

First Edition: October 8, 2013

Today's headlines include the latest on how the health law's online insurance marketplaces are operating and what caused the initial systemic problems.

8 Oct 2013

Researcher receives 2013 Victoria Prize for contributions in quest to eradicate malaria

Malaria researcher Professor Alan Cowman from the Walter and Eliza Hall Institute has been awarded the 2013 Victoria Prize for Science and Innovation in recognition of his outstanding contributions in the quest to eradicate malaria.

8 Oct 2013

Viewpoints: U.S. 'designed for stalemate'; tea party's last stand?; 'war over Obamacare' not over

Though the big social insurance programs are still running, many federal programs that directly target those in the most need are either empty or running on fumes. ... The growth of the modern state is tied to the awareness of public issues in health and the need to address them.

8 Oct 2013

Study aims for new national standard on how doctors and pharmacies write prescriptions

Northwestern Medicine-, Walgreens, Alliance of Chicago community health centers and Merck are collaborating on a study with a deceptively simple goal: provide clear instructions on prescription medicine labels so patients don't make mistakes and overcomplicate taking their daily medications.

8 Oct 2013

Two gene alterations pair up to promote growth of leukemia cells

Two gene alterations pair up to promote the growth of leukemia cells and their escape from anti-cancer drugs, according to a study in The Journal of Experimental Medicine.

8 Oct 2013

Researchers re-invented class of popular antimicrobial drugs by altering their chemical structures

By tinkering with their chemical structures, researchers at the University of California, San Diego School of Medicine have essentially re-invented a class of popular antimicrobial drugs, restoring and in some cases, expanding or improving, their effectiveness against drug-resistant pathogens in animal models.

8 Oct 2013

Two researchers receive $2.5M grant to continue their research on cancer cell growth

A pair of researchers at Rutgers Cancer Institute of New Jersey has been awarded nearly $2.5 million dollars to further study in their respective laboratories.

8 Oct 2013

Supreme Court likely to rule on abortion laws, contraception mandate in new term

The Supreme Court's new session will almost certainly see a ruling on state power to limit the use of some abortion-inducing drugs and one on Arizona's law outlawing abortions after 20 weeks of pregnancy.

8 Oct 2013

Researchers examine how JC polyomavirus enters into cells

For more than a decade the research group of Brown University Professor Walter Atwood has doggedly pursued the workings of the JC polyomavirus, which causes a disease called PML that fatally degrades the central nervous system of patients with weakened immune systems.

8 Oct 2013

The health law and older Americans

A pair of stories examining the health law and Medicare's prescription drug "doughnut hole" as well as what might change for people who are near retirement age, but not yet eligible for Medicare.

8 Oct 2013

New medications may be used to treat common heart-rhythm problem

An international research team led by medical scientists at the University of Alberta has shown that new medications based on resveratrol - a compound found in red wine and nuts - may be used to treat a common heart-rhythm problem known as atrial fibrillation.

8 Oct 2013

Parasites in patients who relapse after leishmaniasis treatment may have greater infectivity

Relapses after treatment for Leishmania infection may be due to a greater infectivity of the parasite rather than drug resistance, as has been previously thought, according to a study published in mBio-, the online open-access journal of the American Society for Microbiology.

8 Oct 2013

NAC amino acid may offer new treatment options for psychiatric disorders

Improved understanding of the roles of inflammation and oxidative stress in psychiatric disorders has generated new leads in the search for novel therapies. One such investigative compound currently in clinical trials is an amino acid, N-Acetyl Cysteine (NAC), which appears to reduce the core symptoms of bipolar disorder, schizophrenia, depression, autism and cravings in addictions including cocaine, cannabis abuse and cigarette smoking.

8 Oct 2013

Scientists devised technique to make antibody-drug conjugates, basis of new therapies

Chemists at The Scripps Research Institute (TSRI) have devised a new technique for connecting drug molecules to antibodies to make advanced therapies.

8 Oct 2013

First Edition: October 7, 2013

Today's headlines include reports detailing the ins and outs of the federal government's online health insurance markeplace as well as the latest from Capitol Hill on the shutdown.

7 Oct 2013

Osteoarthritis and exercise: an interview with Dr Nicola Walsh, Associate Professor at the University of the West of England

Exercise helps to keep the surrounding muscles strong to protect the joint, and also reduces stiffness that people frequently experience in the morning or after periods of inactivity. Joints are meant to move, so keeping them mobile will assist with joint health, maintain range of movement and enhance stability.

7 Oct 2013

Drugs News and Research

Arrowhead initiates Phase 1 study of ARC-520 for treatment against chronic HBV infection

MNK-795 for acute pain management: an interview with Dr Lynn Webster

Forma Achieves First Milestone In Celgene Collaboration

J&J's Janssen Buys Rights To Hepatitis C Compound From GSK

First Edition: October 8, 2013

Researcher receives 2013 Victoria Prize for contributions in quest to eradicate malaria

Viewpoints: U.S. 'designed for stalemate'; tea party's last stand?; 'war over Obamacare' not over

Study aims for new national standard on how doctors and pharmacies write prescriptions

Two gene alterations pair up to promote growth of leukemia cells

Researchers re-invented class of popular antimicrobial drugs by altering their chemical structures

Two researchers receive $2.5M grant to continue their research on cancer cell growth

Supreme Court likely to rule on abortion laws, contraception mandate in new term

Researchers examine how JC polyomavirus enters into cells

The health law and older Americans

New medications may be used to treat common heart-rhythm problem

Parasites in patients who relapse after leishmaniasis treatment may have greater infectivity

NAC amino acid may offer new treatment options for psychiatric disorders

Scientists devised technique to make antibody-drug conjugates, basis of new therapies

First Edition: October 7, 2013

Osteoarthritis and exercise: an interview with Dr Nicola Walsh, Associate Professor at the University of the West of England

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News